Business

Ketamine-Assisted Therapy at Work? The Future of Employee Benefits

November 5, 2024
Featuring: Jessica Tracy

As the mainstreaming of psychedelics continues, ketamine-assisted therapy at work (well, through one’s employer) is no longer a pipe dream. What does the future of employee benefits look like?

Subscribe Share

As the mainstreaming of psychedelics continues, ketamine-assisted therapy at work (well, through one’s employer) is no longer a pipe dream. What does the future of employee benefits look like?

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees.

She talks about her path to psychedelics and how the shifts in her life led her to want to help others, finding Enthea and using her 15 years of experience in healthcare to make an immediate difference. She explains how the process works for an employee of a company Enthea works with, and the importance of evidence-based medical policy and rigorous screening to make sure people are getting the best intervention possible. One of Enthea’s largest clients is Dr. Bronner’s, who reported incredible improvements after employees used the benefit, with a 65% improvement in depression scores and an 86% improvement in PTSD.

She also discusses:

  • How psychedelics bring awareness to what we need to work on
  • Less-discussed treatment modalities, like electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and stellate ganglion block (SGB)
  • The inefficiency of traditional talk therapy: 50% of people only see really good benefits after 20 sessions
  • The importance of viewing mental health as individualized care: What else can we offer to people who haven’t been helped by traditional methods?
  • The research that she wants to see, like measures in how present or productive people are before and after experiences

and more! 

Links

Enthea.com

Thesagecollective.co

PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits, featuring: Sherry Rais

The Economics of Psychedelics, featuring: Elliot Marseille, DrPH, MPP

Unlimitedsciences.org: Ayahuasca for immigrants and refugees

Skylightpsychedelics.com

Healthline.com: What You Need to Know About Transcranial Magnetic Stimulation (TMS) Therapy

Clevelandclinic.org: Stellate Ganglion Block

Nationalacademies.org: Suicide and Mental Health Challenges in the Construction Industry

Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, featuring: Lia Mix, LMFT, CPTR

Jessica Tracy

In this Episode

Jessica Tracy

Jessica Tracy is the Head of Growth & Partnerships at Enthea, an employee benefits solution that helps employers and unions cover psychedelic-assisted therapy (PAT). She leads educational initiatives and partnership expansion efforts across employers, unions, and EAPs. Jessica has also founded The Sage Collective, a purpose led consulting firm whose mission is to integrate psychedelic-assisted therapy into the traditional healthcare ecosystem so that more patients can have access to safe and affordable care. Jessica has nearly 20 years of experience in healthcare, including data analytics, strategy, business development, and consulting. She has expertise in health insurance, clinical genetics & pharmacogenomics, psychedelic medicine, and coaching. Jessica is a certified jungian coach and trained psychedelic facilitator with certifications from the International Jungian Coaching School and SoundMind Institute specializing in psychedelic-assisted therapy. She also holds multiple insurance designations from the Hartford School of Insurance, Commercial Lines Producer School, International Foundation of Employee Benefit Plans, and National Alliance for Insurance Education & Research.

Socials: Linkedin / Enthea linkedin / The Sage Collective linkedin